Skip to main content

Table 4 Adverse events & reinterventions

From: 3-year clinical outcomes of A Singapore VenaSeal™ real world post-market evaluation Study (ASVS) for varicose vein ablation

Adverse events

12 months (n = 90)

36 months (n = 70)

Allergic Skin Reaction (Redness/itch)

0 (0.0)

0 (0.0)

Pulling Sensation

8 (8.9)

2 (2.9)

Newly Developed

 Heaviness

3 (3.3)

2 (2.9)

 Swelling

1 (1.1)

1 (1.4)

 Hyperpigmentation

1 (1.1)

1 (1.4)

Recurrence of symptoms

 Varicosities

0 (0.0)

3 (4.3)

 Heaviness

0 (0.0)

3 (4.3)

 Swelling

3 (3.3)

7 (10.0)

 Ulcers

0 (0.0)

0 (0.0)

Further Interventions for CVI

5 (5.6)

7 (10.0)

 Deep Vein Interrogation

4 (80.0)

4 (57.1)a

 Mean time to Deep Vein Interrogation procedure, months (± SD)

7.6 ± 3.2

11.4 ± 7.6

 Superficial Vein Ablation

1 (20.0)

3 (42.9)b

 Mean Time to SVA procedure, months (± SD)

7.1 (NA)

17.6 ± 1.0

  1. aOne new IVUS/stenting procedure between 1–3 years timepoints
  2. bTwo new below the knee GSV ablation for new symptomatic reflux